CTT Pharmaceutical Holdings, Inc.
What this means
- Change of auditorOn Oct 9, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Total assets | $86K | — |
| Stockholders’ equity | $55K | $32K |
| Cash and equivalents | $15K | $114 |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- CTT PHARMACEUTICAL HOLDINGS, INC.
Formerly: Mindesta Inc. - CIK
- 0001035422
- Tickers
- CTTH
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Florida
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2014
- Last quarterly report
- 10-Q for the quarter ended Jun 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Oct 7, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.